Department of Internal Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital Münster, Münster, Germany.
Department of General and Visceral Surgery, University Hospital Münster, Münster, Germany.
PLoS One. 2019 Mar 13;14(3):e0213608. doi: 10.1371/journal.pone.0213608. eCollection 2019.
Given the gap between patients in need of a renal transplantation (RTx) and organs available, transplantation centers increasingly accept organs of suboptimal quality, e.g. from donors with acute kidney injury (AKI).
To determine the outcome of kidney transplants from deceased donors with AKI (defined as ≥ AKIN stage 1), all 107 patients who received a RTx from donors with AKI between August 2004 and July 2014 at our center were compared to their respective consecutively transplanted patients receiving kidneys from donors without AKI. 5-year patient and graft survival, frequencies of delayed graft function (DGF), acute rejections and glomerular filtration rate (eGFR, CKD-EPI) were assessed.
Patient survival was similar in both groups, whereas death-censored and overall graft survival were decreased in AKI kidney recipients. AKI kidney recipients showed higher frequencies of DGF and had a reduced eGFR at 7 days, three months and one and three years after RTx. However, mortality was noticeably lower compared to waiting list candidates. Rejection-free survival was similar between groups.
In our cohort, both short-term and long-term renal function was inferior in recipients of AKI kidneys, while patient survival was similar. Our data indicates that recipients of donor AKI kidneys should be carefully selected and additional factors impairing short- and long-term outcome should be minimized to prevent further deterioration of graft function.
鉴于需要肾移植(RTx)的患者与可获得的器官之间存在差距,移植中心越来越多地接受质量欠佳的器官,例如来自急性肾损伤(AKI)供体的器官。
为了确定来自 AKI 供体的肾移植(定义为≥AKIN 1 期)的结果,将 2004 年 8 月至 2014 年 7 月期间在我们中心接受 AKI 供体 RTx 的 107 例患者与各自接受无 AKI 供体肾脏的连续移植患者进行比较。评估了 5 年患者和移植物存活率、延迟移植物功能(DGF)、急性排斥反应和肾小球滤过率(eGFR,CKD-EPI)的频率。
两组患者的生存率相似,但 AKI 肾移植受者的死亡风险校正和整体移植物存活率降低。AKI 肾移植受者的 DGF 频率较高,并且在 RTx 后 7 天、3 个月和 1 年和 3 年时 eGFR 降低。然而,与候补名单候选人相比,死亡率明显降低。两组之间的无排斥反应存活率相似。
在我们的队列中,AKI 肾移植受者的短期和长期肾功能均较差,而患者生存率相似。我们的数据表明,应仔细选择 AKI 供体肾移植受者,并应尽量减少影响短期和长期预后的其他因素,以防止移植物功能进一步恶化。